Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Amortization of Deferred Charges (2018 - 2019)

Updated

Abeona Therapeutics' Amortization of Deferred Charges came in at $242,000 for Q3 2019, compared with -$2,000 a year earlier and up 4.8% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Amortization of Deferred Charges (2018 - 2019) Analysis & Trends

Over the trailing twelve months to Sep 30, 2019, Abeona Therapeutics reported Amortization of Deferred Charges of $621,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 242,000.00
Jun 30, 2019 231,000.00
Mar 31, 2019 150,000.00
Sep 30, 2018 -2,000.00
Jun 30, 2018 42,000.00
API Access

Abeona Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ABEO&period=max&api_key=YOUR_API_KEY